Globus Medical, Inc. (GMED) stock analysis
GMED · Globus Medical, Inc.
Latest recorded price: USD 70.56
Model-estimated fair value: USD 91.83. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $70.56, GMED trades 23.2% below the model's base-case value of $91.83. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $70.26 in the conservative case and $117.69 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 42.2%, free cash flow margin 20.0%, ROIC 9.3%. The model does not flag any risk signals for this company.
Similar companies in Healthcare
- Haemonetics Corporation (HAE)
- Integra LifeSciences Holdings Corporation - Common Stock (IART)
- Inspire Medical Systems, Inc. Common Stock (INSP)
- iRadimed Corporation - Common Stock (IRMD)
- iRhythm Holdings, Inc. (IRTC)
- Integer Holdings Corporation Common Stock (ITGR)
- LivaNova PLC (LIVN)
- Medtronic plc. Ordinary Shares (MDT)